PHK
SGMO

Point72 Hong Kong’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Point72 Hong Kong’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,019
Closed -$116K – 2372
2022
Q2 		$116K Buy
28,019
+25,648
+1,082% +$111K ﹤0.01% 1134
2022
Q1 		$14K Sell
2,371
-3,699
-61% -$22K ﹤0.01% 1566
2021
Q4 		$46K Buy
+6,070
New +$52.7K ﹤0.01% 1365
2021
Q3 		– Sell
-11,715
Closed -$140K – 2391
2021
Q2 		$140K Buy
11,715
+11,418
+3,844% +$129K ﹤0.01% 1241
2021
Q1 		$4K Sell
297
-2,692
-90% -$36.3K ﹤0.01% 1674
2020
Q4 		$47K Buy
+2,989
New +$35K ﹤0.01% 1241
2019
Q2 		– Sell
-157
Closed -$1K – 1371
2019
Q1 		$1K Buy
157
+79
+101% +$807 ﹤0.01% 958
2018
Q4 		$1K Buy
+78
New +$969 ﹤0.01% 814
2018
Q2 		– Sell
-622
Closed -$12K – 1151
2018
Q1 		$12K Buy
+622
New +$13.3K 0.01% 682
2017
Q4 		– Sell
-71
Closed -$1K – 1064
2017
Q3 		$1K Sell
71
-871
-92% -$9.63K ﹤0.01% 727
2017
Q2 		$8K Buy
+942
New +$6.04K 0.01% 504

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Point72 Hong Kong's SGMO Position: Q3 2022 in Review

Point72 Hong Kong sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2022, closing a stake of 28,019 shares — an estimated $116K sold.

Point72 Hong Kong first reported a position in SGMO in Q2 2017 and held it in 11 quarters. The position peaked at $140K in Q2 2021. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.

  • Point72 Hong Kong reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 28,019 SANGAMO THERAPEUTICS INC shares in Q3 2022, an estimated $116K.
  • Point72 Hong Kong first reported a position in SANGAMO THERAPEUTICS INC in Q2 2017 and held it in 11 quarters.
  • Point72 Hong Kong's SANGAMO THERAPEUTICS INC position peaked at $140K in Q2 2021.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.